About ARCA
Our Science
Clinical Trials
Collaborations
Investors
Contact Us
About ARCA
Our Science
Clinical Trials
Collaborations
Investors
Contact Us
Investor Relations
Press Releases
[+view all]
04.25.2023
ARCA biopharma Announces First Quarter 2023 Financial Results
03.02.2023
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
12.21.2022
James Flynn Joins ARCA biopharma Board of Directors
About ARCA
Our Science
Clinical Trials
Collaborations
Investors
Contact Us
Investor Relations
Press Releases
[+view all]
04.25.2023
ARCA biopharma Announces First Quarter 2023 Financial Results
03.02.2023
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
12.21.2022
James Flynn Joins ARCA biopharma Board of Directors
Presentations
[GO]
Annual Financial Reports
[GO]
SEC Filings
[GO]
Frequently Asked Questions
[GO]
Corporate Governance
Committee Charters
Audit Committee
Compensation Committee
Nominating & Governance Committee
Governance Documents
Board of Directors Corporate Governance Principles
ARCA biopharma, Inc. Code of Business Conduct and Ethics
ARCA biopharma, Inc. Complaint and Investigation Policy and Procedure
Contact the Board
Chairperson
Member
Audit Committee
Compensation Committee
Nominating & Governance Committee
Raymond L. Woosley, M.D., Ph.D.
Linda Grais, M.D.
Robert E. Conway
Dan Mitchell
Anders Hove, M.D.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok